Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.

Biotechnology

Pharmaceutical

Therapeutics

Immune-Onc Therapeutics

Charlene Liao

Helen Y.

Ying Zhu

Xiao Min Schebye

Sydney Ray

Roya Nawabi

Penny Dong

tao Huang

Hong Xiang

Maggie Gu

Directors Team

Scientific and Clinical Team

Leadership Team

Teams at Immune-Onc Therapeutics

Directors Team

Scientific and Clinical Team

Leadership Team